litlas
ログインアカウント作成

Anna Mae Diehl

1984–2025 年に発表

別表記
Anna‐Mae Diehl
260
論文数
64,128
被引用数
131
h 指数
252
i10 指数

被引用数

Anna Mae Diehl の年別被引用数1978 年: 被引用 1 件1983 年: 被引用 2 件1985 年: 被引用 1 件1986 年: 被引用 4 件1987 年: 被引用 1 件1988 年: 被引用 4 件1989 年: 被引用 2 件1990 年: 被引用 5 件1991 年: 被引用 8 件1992 年: 被引用 8 件1993 年: 被引用 7 件1994 年: 被引用 30 件1995 年: 被引用 35 件1996 年: 被引用 28 件1997 年: 被引用 50 件1998 年: 被引用 93 件1999 年: 被引用 128 件2000 年: 被引用 174 件2001 年: 被引用 258 件2002 年: 被引用 363 件2003 年: 被引用 304 件2004 年: 被引用 479 件2005 年: 被引用 424 件2006 年: 被引用 448 件2007 年: 被引用 470 件2008 年: 被引用 547 件2009 年: 被引用 563 件2010 年: 被引用 672 件2011 年: 被引用 628 件2012 年: 被引用 684 件2013 年: 被引用 790 件2014 年: 被引用 773 件2015 年: 被引用 819 件2016 年: 被引用 917 件2017 年: 被引用 807 件2018 年: 被引用 846 件2019 年: 被引用 2,276 件2020 年: 被引用 2,554 件2021 年: 被引用 2,577 件2022 年: 被引用 2,126 件2023 年: 被引用 1,638 件2024 年: 被引用 2,369 件2025 年: 被引用 1,336 件2026 年: 被引用 52 件1979〜1982 年は被引用が無いため表示していません1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,416 件、この内訳の 25.6%中国: 引用元論文 3,596 件、この内訳の 14.4%イギリス: 引用元論文 1,352 件、この内訳の 5.4%イタリア: 引用元論文 1,344 件、この内訳の 5.4%ドイツ: 引用元論文 1,068 件、この内訳の 4.3%日本: 引用元論文 893 件、この内訳の 3.6%フランス: 引用元論文 825 件、この内訳の 3.3%スペイン: 引用元論文 808 件、この内訳の 3.2%韓国: 引用元論文 685 件、この内訳の 2.7%カナダ: 引用元論文 544 件、この内訳の 2.2%オーストラリア: 引用元論文 507 件、この内訳の 2%インド: 引用元論文 457 件、この内訳の 1.8%
0%25.6%その他 26.1%

機関

分野

  • Medicine74.7%
  • Biochemistry, Genetics and Molecular Biology16.9%
  • Neuroscience2.1%
  • Immunology and Microbiology2%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Nursing0.8%
  • その他2.6%

トピック

  • Liver Disease Diagnosis and Treatment20.5%
  • Diet, Metabolism, and Disease5.6%
  • Liver Disease and Transplantation4.4%
  • Liver physiology and pathology3.7%
  • Alcohol Consumption and Health Effects3.4%
  • Diet and metabolism studies2.4%
  • その他60%

共著者

全論文

検索で開く
  1. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

    著者: Arun J. Sanyal, Mark L. Van Natta, Jeanne M. Clark, Brent A. Neuschwander‐Tetri, Anna‐Mae Diehl, Srinivasan Dasarathy, Rohit Loomba, Naga Chalasani, Kris V. Kowdley, Bilal Hameed, Laura Wilson, Katherine P. Yates, Patricia Belt, Mariana Lazo, David E. Kleiner, Cynthia Behling, James Tonascia - New England Journal of Medicine 2021 被引用: 1,065

  2. Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

    著者: Arun J. Sanyal, Naga Chalasani, Kris V. Kowdley, Arthur J. McCullough, Anna Mae Diehl, Nathan M. Bass, Brent A. Neuschwander‐Tetri, Joel E. Lavine, James Tonascia, Aynur Ünalp, Mark L. Van Natta, Jeanne M. Clark, Elizabeth M. Brunt, David E. Kleiner, Jay H. Hoofnagle, Patricia R. Robuck - New England Journal of Medicine 2010 被引用: 3,297

  3. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

    著者: Jérôme Boursier, Olaf Mueller, Matthieu Barret, Mariana Verdelho Machado, Lionel Fizanne, Félix Araújo-Pérez, Cynthia D. Guy, Patrick C. Seed, John F. Rawls, Lawrence A. David, Gilles Hunault, Frédéric Oberti, Paul Calès, Anna Mae Diehl - Hepatology 2015 被引用: 1,457

  4. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

    著者: Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal, Joel E. Lavine, Mark L. Van Natta, Manal F. Abdelmalek, Naga Chalasani, Srinivasan Dasarathy, Anna Mae Diehl, Bilal Hameed, Kris V. Kowdley, Arthur J. McCullough, Norah A. Terrault, Jeanne M. Clark, James Tonascia, Elizabeth M. Brunt, David E. Kleiner, Edward Doo - The Lancet 2014 被引用: 2,185

  5. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

    著者: Anna Mae Diehl, Christopher P. Day - New England Journal of Medicine 2017 被引用: 1,307

  6. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

    著者: Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal - Hepatology 2012 被引用: 3,823

  7. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease

    著者: Thomas Jensen, Manal F. Abdelmalek, Shelby Sullivan, Kristen J. Nadeau, Melanie Cree‐Green, Carmen Roncal, Takahiko Nakagawa, Masanari Kuwabara, Yuka Sato, Duk‐Hee Kang, Dean R. Tolan, Laura Gabriela Sánchez‐Lozada, Hugo R. Rosen, Miguel A. Lanaspa, Anna Mae Diehl, Richard J. Johnson - Journal of Hepatology 2018 被引用: 917

  8. Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study

    著者: Daniel Q. Huang, Laura Wilson, Cynthia Behling, David E. Kleiner, Kris V. Kowdley, Srinivasan Dasarathy, Maral Amangurbanova, Norah A. Terrault, Anna Mae Diehl, Naga Chalasani, Brent A. Neuschwander‐Tetri, Arun J. Sanyal, James Tonascia, Daniela Allende, Annette Bellar, Jaividhya Dasarathy, Srinivasan Dasarathy, Nicole Welch, Rahul Yerrapothu, Mustafa R. Bashir, Anna Mae Diehl, Cynthia D. Guy, Mariko Kopping, Dawn Piercy, Ayako Suzuki, Naglaa Tawadrou, Naga Chalasani, Mandy Cruz, Oscar W. Cummings, Lisa Garrison, Samer Gawrieh, Niharika Samala, Raj Vuppalanchi, Danielle Carpenter, Theresa Cattoor, Janet Freebersyser, Brent A. Neuschwander‐Tetri, Pannapat Angkanaworakul, Achashman Berihun, Andrew Buysse, Theresa Dorrian, Breanna Gulati, Kris V. Kowdley, Kevin Liu, S Misić, Adam Sohal, J. Vuong, Veeral Ajmera, Cynthia Behling, Rohit Loomba, Egbert Madamba, Michael S. Middleton, Lisa Richards, Seema Singh, Claude B. Sirlin, Ryan M. Gill, Bilal Hameed, Remilekun Awe, Daisy Rios Olvera, Norah A. Terrault, Liyun Yuan, Matthew M. Yeh, Somaya Albhaisi, Amon Asgharpour, Sherry Boyett, Melissa J. Contos, Velimir A. Luketic, Arun J. Sanyal, Jolene Schlosser, Mohammad Shadab Siddiqui, David E. Kleiner, Peggy Adamo, Patricia Belt, Jeanne M. Clark, Jennifer DeSanto, Jill Meinert, Laura Miriel, Emily Mitchell, Carrie Shade, Jacqueline Smith, Michael L. Smith, Alice Sternberg, James Tonascia, Mark L. Van Natta, Annette Wagoner, Laura A. Wilson, Tinsay A. Woreta, Katherine P. Yates, Rohit Loomba - Gastroenterology 2023 被引用: 167

  9. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells

    著者: Kuo Du, Jeongeun Hyun, Richard T. Premont, Steve S. Choi, Gregory Michelotti, Marzena Swiderska‐Syn, George D. Dalton, Eric Thelen, Bahar Salimian Rizi, Youngmi Jung, Anna Mae Diehl - Gastroenterology 2018 被引用: 331

  10. Pathogenesis of Nonalcoholic Steatohepatitis

    著者: Mariana Verdelho Machado, Anna Mae Diehl - Gastroenterology 2016 被引用: 531

  11. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

    著者: Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal - Gastroenterology 2012 被引用: 1,774

  12. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

    著者: David E. Kleiner, Elizabeth M. Brunt, Laura Wilson, Cynthia Behling, Cynthia D. Guy, Melissa J. Contos, Oscar W. Cummings, Matthew M. Yeh, Ryan M. Gill, Naga Chalasani, Brent A. Neuschwander‐Tetri, Anna Mae Diehl, Srinivasan Dasarathy, Norah A. Terrault, Kris V. Kowdley, Rohit Loomba, Patricia Belt, James Tonascia, Joel E. Lavine, Arun J. Sanyal - JAMA Network Open 2019 被引用: 367

  13. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

    著者: Stephen A. Harrison, Manal F. Abdelmalek, Stephen H. Caldwell, Mitchell L. Shiffman, Anna Mae Diehl, Reem Ghalib, Eric Lawitz, Don C. Rockey, Raul Aguilar Schall, Catherine Jia, B. Mccolgan, John G. McHutchison, G. Mani Subramanian, Robert P. Myers, Zobair M. Younossi, Vlad Ratziu, Andrew J. Muir, Nezam H. Afdhal, Zachary Goodman, Jaime Bosch, Arun J. Sanyal - Gastroenterology 2018 被引用: 372

  14. The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

    著者: Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl, Stephen H. Caldwell, Mitchell L. Shiffman, Raul Aguilar Schall, Catherine Jia, B. Mccolgan, C. Stephen Djedjos, John G. McHutchison, G. Mani Subramanian, Robert P. Myers, Zobair M. Younossi, Andrew J. Muir, Nezam H. Afdhal, Jaime Bosch, Zachary Goodman - Hepatology 2019 被引用: 389

  15. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis

    著者: Changyu Zhu, KyeongJin Kim, Xiaobo Wang, Alberto Bartolomé, Marcela Salomao, Paola Dongiovanni, Marica Meroni, Mark J. Graham, Katherine P. Yates, Anna Mae Diehl, Robert F. Schwabe, Ira Tabas, Luca Valenti, Joel E. Lavine, Utpal B. Pajvani - Science Translational Medicine 2018 被引用: 242

  16. NAFLD, NASH and liver cancer

    著者: Gregory Michelotti, Mariana Verdelho Machado, Anna Mae Diehl - Nature Reviews Gastroenterology & Hepatology 2013 被引用: 964

  17. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis

    著者: Ju Dong Yang, Manal F. Abdelmalek, Herbert Pang, Cynthia D. Guy, Alastair D. Smith, Anna Mae Diehl, Ayako Suzuki - Hepatology 2013 被引用: 375

  18. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage

    著者: Mohammad Shadab Siddiqui, Goro Yamada, Raj Vuppalanchi, Mark L. Van Natta, Rohit Loomba, Cynthia D. Guy, Danielle Brandman, James Tonascia, Naga Chalasani, Brent A. Neuschwander‐Tetri, Arun J. Sanyal, Daniela Allende, Srinivasan Dasarathy, Arthur J. McCullough, Revathi Penumatsa, Jaividhya Dasarathy, Joel E. Lavine, Manal F. Abdelmalek, Mustafa R. Bashir, Stephanie Buie, Anna Mae Diehl, Cynthia D. Guy, Christopher Kigongo, Mariko Kopping, David Malik, Dawn Piercy, Naga Chalasani, Oscar W. Cummings, Samer Gawrieh, Linda Ragozzino, Kumar Sandrasegaran, Raj Vuppalanchi, Elizabeth M. Brunt, Theresa Cattoor, Danielle Carpenter, Janet Freebersyser, Debra King, Jinping Lai, Brent A. Neuschwander‐Tetri, Joan Siegner, Susan L. Stewart, Susan Torretta, Kristina Wriston, Maria Cardona Gonzalez, Jodie Davila, Manan Jhaveri, Kris V. Kowdley, Nizar A. Mukhtar, Erik Ness, Michelle Poitevin, Brook A. Quist, Sherilynn Soo, Brandon Ang, Cynthia Behling, Archana Bhatt, Rohit Loomba, Michael S. Middleton, Claude B. Sirlin, Maheen F. Akhter, Nathan M. Bass, Danielle Brandman, Ryan M. Gill, Bilal Hameed, Jacqueline Maher, Norah A. Terrault, Ashley Ungermann, Matthew M. Yeh, Sherry Boyett, Melissa J. Contos, S. Kirwin, Velimir A. Luketic, Puneet Puri, Arun J. Sanyal, Jolene Schlosser, Mohammad Shadab Siddiqui, Leslie Yost-Schomer, Elizabeth M. Brunt, Kathryn J. Fowler, David E. Kleiner, Edward Doo, Sherry Hall, Jay H. Hoofnagle, Jessica J. Lee, Patricia R. Robuck, Averell H. Sherker, Rebecca Torrance, Patricia Belt, Jeanne M. Clark, J.A. Dodge, Michele Donithan, Erin Hallinan, Milana Isaacson, Mariana Lazo, Jill Meinert, Laura Miriel, Jacqueline Smith, Michael L. Smith, Alice Sternberg, James Tonascia, Mark L. Van Natta ほか 4 名 - Clinical Gastroenterology and Hepatology 2019 被引用: 268

  19. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

    著者: Rohit Loomba, Eric Lawitz, Parvez Mantry, Saumya Jayakumar, Stephen H. Caldwell, Hays Arnold, Anna Mae Diehl, C. Stephen Djedjos, Ling Han, Robert P. Myers, G. Mani Subramanian, John G. McHutchison, Zachary Goodman, Nezam H. Afdhal, Michael Charlton, for the GS‐US‐384‐1497 Investigators - Hepatology 2017 被引用: 553

  20. Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease

    著者: Anastasia‐Stefania Alexopoulos, Matthew J. Crowley, Ying Wang, Cynthia A. Moylan, Cynthia D. Guy, Ricardo Henao, Dawn Piercy, Keri A. Seymour, Ranjan Sudan, Dana Portenier, Anna Mae Diehl, Andrea D. Coviello, Manal F. Abdelmalek - Hepatology 2021 被引用: 127

  21. Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis

    著者: Kuo Du, Raquel Maeso‐Díaz, Seh Hoon Oh, Ergang Wang, Tianyi Chen, Christopher S. Pan, Kun Xiang, Rajesh Kumar Dutta, Xiao‐Fan Wang, Jen‐Tsan Chi, Anna Mae Diehl - Hepatology 2023 被引用: 91

  22. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

    著者: Kanji Yamaguchi, Liu Yang, Shannon J. McCall, Jiawen Huang, Xing Yu, Sanjay Pandey, Sanjay Bhanot, Brett P. Monia, Yin-xiong Li, Anna Mae Diehl - Hepatology 2007 被引用: 1,001

  23. Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic

    著者: Donna L. Mendrick, Anna Mae Diehl, Lisa Swartz Topor, Rodney R. Dietert, Yvonne Will, Michele A. La Merrill, Sébastien G. Bouret, Vijayalaskshmi Varma, Kenneth L. Hastings, Thaddeus T. Schug, Susan Hart, FLORENCE G. BURLESON - Toxicological Sciences 2017 被引用: 259

  24. Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease

    著者: Arun J. Sanyal, Stephen A. Williams, Joel E. Lavine, Brent A. Neuschwander‐Tetri, Leigh Alexander, Rachel Ostroff, Hannah Biegel, Kris V. Kowdley, Naga Chalasani, Srinivasan Dasarathy, Anna Mae Diehl, Rohit Loomba, Bilal Hameed, Cynthia Behling, David E. Kleiner, Saul J. Karpen, Jessica Williams, Yi Jia, Katherine P. Yates, James Tonascia - Journal of Hepatology 2022 被引用: 97